Equity · Healthcare
NGNE
NASDAQNeurogene (NGNE)
The line runs 40 USD on 24 August through 22.15 USD on 20 November, on a scale from 20 to 50. Days the market did not trade hold the previous close, flat.
- Market cap
- 458.5M USD
- Revenue, year to Dec 2025
- 0 USD
- EPS, diluted, year to Dec 2025
- −4.24 USD
- 52-week range
- 16 USD – 43 USD
- Avg volume
- 11.2K
- Mentions, 30 days
- 1
as of Nov 20, 2026
Have Neurogene (NGNE) insiders bought or sold shares recently?
In the 90 days to 22 Nov 2026, no Neurogene insider bought or sold shares on the open market; the 1 Form 4 filing in that window was a grant, exercise, tax withholding or transfer (SEC Form 4).
Form 4, 90 days to 22 Nov 2026, newest Form 4 filing 22 Sep 2026
| Reported | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 22 Sep 2026 | McMinn RachelChief Executive Officer | Option exercise | 756 | 19K USD |
Which funds hold Neurogene (NGNE)?
8 of the 45 institutional funds we track reported a Neurogene position for the quarter ended 30 Sep 2026 — a combined 51.4M USD; the latest of those filings landed 16 Nov 2026.
| Fund | Position | Shares | Value | Shares q/q |
|---|---|---|---|---|
| Baker Bros. Advisors | Held (±25%) | 991,691 | 27.6M USD | |
| Balyasny Asset Management | Trimmed | 303,994 | 8.5M USD | −62.9% |
| Point72 Asset Management | Added | 238,967 | 6.6M USD | +68.4% |
| Marshall Wace | New position | 168,509 | 4.7M USD | |
| Citadel Advisors | Trimmed | 92,858 | 2.6M USD | −77.3% |
| Millennium Management | Trimmed | 24,633 | 685K USD | −42.4% |
| AQR Capital Management | Held (±25%) | 15,185 | 422K USD | +0.8% |
| Renaissance Technologies | Trimmed | 10,205 | 284K USD | −50.0% |
| D. E. Shaw & Co. | Exited |
What has been filed or recorded for Neurogene (NGNE)?
The filings we hold for Neurogene, newest first: 7 fails-to-deliver days, 6 quarterly earnings reports, 2 annual reports and 5 reported financial figures, the latest dated 30 Oct 2026. No next earnings date is announced in SEC filings yet.
| And | ||||
|---|---|---|---|---|
| 30 Oct 2026 | Fails to deliver | Shares failed to deliver | 6 shares | 173 USD notional · <0.001% of shares out |
| 29 Oct 2026 | Fails to deliver | Shares failed to deliver | 11,639 shares | 354K USD notional · 0.056% of shares out |
| 28 Oct 2026 | Fails to deliver | Shares failed to deliver | 6 shares | 162 USD notional · <0.001% of shares out |
| 14 Oct 2026 | Fails to deliver | Shares failed to deliver | 88 shares | 2K USD notional · <0.001% of shares out |
| 13 Oct 2026 | Fails to deliver | Shares failed to deliver | 20 shares | 489 USD notional · <0.001% of shares out |
| 09 Oct 2026 | Fails to deliver | Shares failed to deliver | 500 shares | 13K USD notional · 0.002% of shares out |
| 07 Oct 2026 | Fails to deliver | Shares failed to deliver | 503 shares | 13K USD notional · 0.002% of shares out |
| 30 Sep 2026 | Quarterly earnings | Q3 2026 reported | EPS −1.05 USD | |
| 30 Sep 2026 | Financials | Total assets | 377.9M USD | at period end |
| 30 Sep 2026 | Financials | Total equity | 354.8M USD | at period end |
| 30 Jun 2026 | Quarterly earnings | Q2 2026 reported | EPS −1.53 USD | |
| 31 Mar 2026 | Quarterly earnings | Q1 2026 reported | EPS −1.39 USD | |
| 31 Dec 2025 | Annual report | FY 2025 reported | EPS −4.24 USD | |
| 31 Dec 2025 | Financials | Revenue | 0 USD | fiscal year |
| 31 Dec 2025 | Financials | Net income | −90.4M USD | fiscal year |
| 31 Dec 2025 | Financials | Diluted EPS | −4.24 USD | fiscal year |
| 30 Sep 2025 | Quarterly earnings | Q3 2025 reported | EPS −0.99 USD | |
| 30 Jun 2025 | Quarterly earnings | Q2 2025 reported | EPS −1.05 USD | |
| 31 Mar 2025 | Quarterly earnings | Q1 2025 reported | EPS −1.08 USD | |
| 31 Dec 2024 | Annual report | FY 2024 reported | EPS −4.28 USD | Revenue $1M |
What is Reddit saying about Neurogene (NGNE)?
Reddit mentioned NGNE 1 times in the 30 days to 21 November 2026, in 1 of the communities we track. All of them were scored for sentiment: 100% read bullish, 0% bearish and 0% neither. Reddit data updated 21 November 2026.
30-day window, Method
How do Reddit mentions of Neurogene (NGNE) compare with its price?
Share ↗
Which subreddits are talking about Neurogene (NGNE)?
30 days
| Community | Share | Mentions | Net sentiment |
|---|---|---|---|
| r/stocks | 100% | 1 | +0.22 |
What do people ask about Neurogene (NGNE)?
What did Neurogene shares close at?22.15
Neurogene closed at 22.15 USD on 20 Nov 2026, down 3.40% on the close before. That is the end-of-day price from Finazon, not a live quote.
What is Neurogene’s market cap?458.5M
Neurogene is worth 458.5M USD by market value as of 20 Nov 2026, which is the share price times the shares on issue from its SEC filings.
What is Neurogene’s revenue?0
Neurogene reported revenue of 0 USD for the year ended 31 Dec 2025, as filed with the SEC. See Filings
Have Neurogene insiders bought or sold shares recently?1 filing
In the 90 days to 22 Nov 2026, no Neurogene insider bought or sold shares on the open market; the 1 Form 4 filing in that window was a grant, exercise, tax withholding or transfer (SEC Form 4). See Insiders
Which funds own Neurogene?8 of 45
8 of the 45 funds we track reported a Neurogene position for the quarter ended 30 Sep 2026, per their SEC Form 13F filings. The largest reported positions were Baker Bros. Advisors, Balyasny Asset Management and Point72 Asset Management. See Funds
When did Neurogene last report earnings?−1.05
Neurogene last reported earnings on 30 Sep 2026 for Q3 2026, with EPS of −1.05 USD; no next date is announced in SEC filings yet. See Filings
What is Reddit saying about Neurogene?0 mentions
Neurogene was mentioned 0 times in the last 7 days across the finance subreddits we track, and 1 times over the trailing 30 days. Of the 1 mentions scored for sentiment, 100% read bullish and 0% bearish. That is a social signal, not investment advice. See Reddit

Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.
References
- Finazonprior-day close, indicative (IEX-derived, not the official close), some closes dollar-rounded at the source
- TradingViewthe price chart widget, drawn by TradingView from their own data
- RedditReddit ingest across the tracked finance subreddits
- SEC EDGARForm 4 filings (insider transactions)
- SEC EDGAR13F filings
- SECSEC fails-to-deliver (CNS) data
- SEC EDGARXBRL company facts, latest period ended 30 Sep 2026
- SEC EDGARreported earnings figures and scheduled report dates
- SEC EDGARValuation computed from SEC EDGAR filings
- SEC filingAbout text: the company's latest annual report filed with the SEC (Business section), summarised in our own words